A 67-year-old African American male recently diagnosed with metastatic renal cell carcinoma presents to clinic for evaluation of pruritic and burning skin findings (see clinical images below) that developed two weeks after he started treatment with bevacizumab and erlotinib. Which of the following medications would not cause this eruption?

A. Cetuximab

B. Erlotinib

C. Panitumumab

D. Bevacizumab

E. Gefitinib

To find out the correct answer and read the explanation, click here.

Brought to you by our Brand Partner